Aliceblue ANT
Aliceblue ANTInstall and trade smarter everywhere
O

OSEL Devices Ltd

Complete IPO details, including price band, financials, subscription status, and key insights.

Participate in the OSEL Devices Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.

IPO Snapshot

Key metrics and details at a glance.

Price Band

₹160

Per Share

Lot Size

800 Shares

Minimum Investment

₹1,28,000

Issue Size

₹70.66 Cr

Face Value

₹10

Per Share

IPO Type

Book Building - SME

Retail Quota

35%

QIB Quota

50%

NII Quota

15%

IPO Timeline

Important dates for your applying strategy.

IPO Opens16 Sept
IPO Closes19 Sept
Basis of Allotment20 Sept
Refund Initiation23 Sept
Shares Credited23 Sept
Listing Date24 Sept
IPO Process Completed

Subscription Status

Live demand across investor categories.

Track real-time subscription levels:

*Real-time data subject to exchange updates

Qualified Institutional Buyers (QIB)0.00x
Non-Institutional Investors (NII)0.00x
Retail Individual Investors (RII)0.00x
Overall Subscription180.68x

OSEL Devices Ltd

Business model, operations, and market positioning.

Promoter Holding (Pre-Issue)

98.5%

Promoter Holding (Post-Issue)

71.53%

Issue Type

Book Building - SME

ISIN

INE0RMF01018

About the Company

The Company manufactures comprehensive range of LED display systems. It is equipped with software and hardware capabilities. Its LED display systems are enabled with content management system which allows it to connect to phone or computer and display on screen. Equipped with the latest technology and adhering to rigorous quality control standards, the company produces a wide range of high-performance components and systems. This vertical integration ensures consistency and excellence in every product it delivers. The LED display systems manufactured by the company has been used by corporate for commercial usage such as advertising media, billboards, corporate meeting rooms, presentations, display promotions, command control centre and front sign boards. The Company also manufactures latest hearing aids commonly known as assisted healthcare devices. Its hearing aids are designed to support individuals with disabilities, elderly person and chronic patients, who are having low hearing level, in performing everyday activities more effectively to enhance quality of life. Its major customer for hearing aid is Artificial Limbs Manufacturing Corporation of India. The Company manufactures Digital Programable and Non-Programmable Hearing Aids.

Industry Overview

More than three years after the global economy suffered the largest shock of the past 75 years, the wounds are still healing, amid widening growth divergences across regions. After a strong initial rebound from the depths of the COVID-19 pandemic, the pace of recovery has moderated. Several forces are holding back the recovery. Some reflect the long-term consequences of the pandemic, Russia's war in Ukraine, and increasing geoeconomic fragmentation. Others are more cyclical, including the effects of monetary policy tightening necessary to reduce inflation, withdrawal of fiscal support amid high debt, and extreme weather events. Despite signs of economic resilience earlier this year and progress in reducing headline inflation, economic activity is still generally falling short of pre-pandemic (January 2020) projections, especially in emerging market and developing economies.

Company History

Osel Devices Limited (the "Company" or the "Issuer") was incorporated on August 14, 2006 as a private limited company under the name and style of `Innovative Infratech Soultions Private Limited', under the Companies Act, 1956, pursuant to a certificate of incorporation dated August 14, 2006 issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, in order to rectify the transposition error in the name of the Company, pursuant to a resolution passed by its Board of Directors in its meeting held on November 6, 2013, and by the Shareholders in their Extraordinary General Meeting held on November 8, 2013, the name of the Company was changed to `Innovative Infratech Solutions Private Limited' and a fresh certificate of incorporation dated November 22, 2013 was issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana. Subsequently, pursuant to a resolution passed by its Board of Directors in its meeting held on November 13, 2023, and by the Shareholders in their extraordinary general meeting held on December 15, 2023, in order to reflect the main business activity of the Company and for better branding, the name of the Company was changed to `Osel Devices Private Limited' and a fresh certificate of incorporation dated January 16, 2024 was issued by the Registrar of Companies, Delhi and Haryana at Delhi. Further, the Company was converted into a public limited company pursuant to a resolution passed by its Board of Directors in its meeting held on March 15, 2024, and by the Shareholders in an extraordinary general meeting held on March 22, 2024 and consequently the name of the Company was changed to `Osel Devices Limited' and a fresh certificate of incorporation dated May 2, 2024 was issued by the Registrar of Companies, Central Processing Centre.

Products & Services

  • The Company manufactures a comprehensive range of LED display systems and the latest hearing aids.

Growth Strategy

  • Market Penetration and Geographic Expansion.
  • Embracing new technologies for Product Diversification and Innovation.
  • Focus on our Quality Control.
  • Marketing Strategy.
  • Growing its business with existing clients with quality and efficient services.
  • Reduction of operational costs and achieving efficiency.

Customer Base

Artificial Limbs Manufacturing Corporation of India

Financial Performance

Revenue, profit after tax and total assets across the last 3 reported financial years.

Standalone figures
Financial Performance Categories

Revenue

+128%vs FY23

Amount in ₹ crore

81.9
132
186
FY23FY24FY25

Profit After Tax (PAT)

+330%vs FY23

Amount in ₹ crore

4.66
12.7
20.1
FY23FY24FY25

Total Assets

+304%vs FY23

Amount in ₹ crore

49.0
98.6
198
FY23FY24FY25

Figures in ₹ crore, on a standalone basis, as reported for FY23 to FY25.

Objects of the Issue

How the company plans to utilize IPO proceeds.

Use of Proceeds

The funds raised through this IPO will be used for:

Initial public offer of upto 44,16,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of the company at an issue price of Rs. 160 per equity share (including a share premium of Rs. 150 per equity share) for cash, aggregating up to Rs. 70.66 crores ("Public Issue") out of which 2,21,600 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 160 per equity share for cash, aggregating Rs. 3.55 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 41,94,400 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 160 per equity share for cash, aggregating up to Rs. 67.11 crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 27.38% and 26.01% respectively of the post-issue paid-up equity share capital of the company. The Offer Price is Rs. 160 per equity share of face value of Rs. 10 each. The Offer Price is 16 times of the face value of the equity shares. Bid cane be made for a minimum of 800 equity shares and in multiples of 800 equity shares thereafter.

*Subject to approvals and market conditions.

Strengths & Risks

Key competitive advantages and factors to consider before investing.

Strengths and Risk Factors
  • One of the leading specialized LED display system and hearing aids manufacturer with long standing market presence.
  • Geographical presence.
  • Quality Assurance and Quality Control of its products.
  • Strong, cordial & long-term relationship with its clients.
  • Cost effective production and timely fulfilment of orders.
  • Its commercial success is largely dependent upon the company ability to develop and design innovative products suitable for the requirements of its customers. The company inability to effectively utilize and manage its ability to develop and design innovative products would impact its business, revenue and profitability.
  • The Company is reliant on the demand from the healthcare industry for a significant portion of its revenue. Any downturn in the healthcare industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.
  • The commercial success of its products depends to a large extent on the success of the products of its end use customers. If the demand for the end use products in which its products are used as a raw materials declines, it could have a material adverse effect on its business, financial condition and results of operations.
  • The company depends on a few customers of its products, for a significant portion of the company revenue, and any decrease in revenues or sales from any one of its key customers may adversely affect its business and results of operations.
  • The company generates its major portion of sales from its operations in certain geographical regions. Any adverse developments affecting its operations in these regions could have an adverse impact on its revenue and results of operations.

Frequently Asked Questions

01

What is the minimum investment required to apply for this IPO?

The minimum investment depends on the lot size and the upper price band of the issue. Investors must apply for at least one lot, and the total investment amount is calculated by multiplying the lot size by the upper price band.
02

How is IPO allotment decided?

IPO allotment is determined based on demand and SEBI guidelines. If the IPO is oversubscribed in the retail category, allotment is typically done through a computerized lottery system to ensure fair distribution among eligible applicants.
03

When will I know if shares are allotted to me?

Allotment status is usually finalized a few days after the IPO closes. Once finalized, shares are either credited to your Demat account (if allotted) or the blocked funds are released back to your bank account.
04

Can I modify or cancel my IPO application?

Yes, you can modify or cancel your IPO application anytime before the IPO closing date. Changes can be made through your Alice Blue account, subject to exchange cut-off timings.
05

What happens if the IPO is oversubscribed?

If the IPO receives more applications than the number of shares available, it is considered oversubscribed. In such cases, allotment in the retail category is done on a proportionate or lottery basis, and not all applicants may receive shares.
OSEL Devices Ltd IPO Status, GMP, Price & Dates Today | Alice Blue